Buprenorphine Induction in the Fentanyl Era: Standard Wait vs. Low-Dose Micro-Induction
A patient has twice left treatment intake rather than wait through the withdrawal severity a standard buprenorphine induction requires. A newer, less-studied low-dose protocol is built for exactly this problem — but it is genuinely less proven.
A.N.'s older brother drove him in today and is waiting in the lobby, having rearranged his own work schedule to do it — the third time now he's made that drive, after two prior attempts that ended before A.N. was even seen. He is twenty-seven. Both previous times he left once he heard he'd need to be in significant withdrawal first; this time he stayed. His opioid use has been exclusively illicit fentanyl for the past year, smoked rather than injected, after a longer period of prescription opioid use that started with a wisdom-tooth extraction in his early twenties and escalated once his prescriptions stopped and a friend introduced him to what was available on the street instead.
He used roughly six hours before this visit and is not currently in withdrawal — his Clinical Opiate Withdrawal Scale score is 4, essentially subclinical, with only mild restlessness and slight pupil dilation on exam. That gap is exactly what has derailed him before: he cannot tolerate the wait required to reach the withdrawal severity a standard buprenorphine induction calls for, and has left rather than sit with escalating symptoms he knows from experience will feel unbearable well before they're “textbook enough” to safely start. He has no other chronic medical conditions, and no prior overdose requiring reversal that he knows of, though he's aware of at least one close call last winter he doesn't remember clearly, described to him afterward by someone else who was there. A.N. works occasional day-labor shifts when he can get them, nothing steady since his last warehouse job ended when his attendance became unreliable.
Waiting for textbook withdrawal has already failed him twice
I'd start a low-dose micro-induction protocol today, right now, rather than send him home to wait for a higher COWS score. His documented pattern across two prior attempts is disengaging during exactly that wait — not disliking buprenorphine, not changing his mind about treatment, leaving specifically because the withdrawal-wait itself was unbearable. Published case series describe successful induction using small, gradually escalating doses started before standard withdrawal criteria are met, developed specifically for patients with heavy fentanyl exposure like his.
I understand the logic, but I want to be honest about how much less mature this evidence base is compared to standard induction. Most of what supports micro-induction comes from case series and small cohorts, with real variability in dosing schedules between published protocols — not the kind of large randomized data we have for waiting to a COWS of 8 or higher before dosing.
And "his documented pattern is disengaging during the wait" cuts both ways: the two attempts he walked out of were intake appointments, not dosing failures. That's an argument for changing how we hold onto him during the wait — same-day dosing, his brother in the room — before it's an argument for changing the induction protocol itself.
"Less studied" isn't the same as "unsafe," though — and the standard protocol's own real-world failure rate in patients exactly like him, heavy fentanyl users who disengage during the wait, is not zero either. We aren't comparing a proven approach to an unproven one; we're comparing one real-world failure mode to a different, better-matched one.
Agreed on the rest — and we're not abandoning caution, just changing where it's applied. We start at a genuinely small dose, escalate slowly over several days rather than hours, and keep him and his brother here or reachable for close monitoring during the first critical window rather than sending him home unsupervised on day one. If precipitated withdrawal does emerge despite the small starting dose, we manage it directly rather than treating today's plan as fixed.
Agreed: low-dose micro-induction started today, with close monitoring over the first 48 to 72 hours and his brother included in a plan for what to watch for and when to call.
Not agreed: whether micro-induction should become the default offered to every heavy-fentanyl-use patient at intake, or remain reserved for patients like A.N. with a specifically documented standard-induction failure pattern. The addiction medicine specialist sees his case as evidence the default itself should shift; the emergency medicine physician wants to see the evidence base mature further before generalizing beyond patients who have already failed the standard approach.